Zobrazeno 1 - 8
of 8
pro vyhledávání: '"N. Rocio Mosqueira"'
Autor:
D Scott LaMontagne, Sandhya Barge, Nga Thi Le, Emmanuel Mugisha, Mary E Penny, Sanjay Gandhi, Amynah Janmohamed, Edward Kumakech, N Rocio Mosqueira, Nghi Quy Nguyen, Proma Paul, Yuxiao Tang, Tran Hung Minh, Bella Patel Uttekar, Aisha O Jumaan
Publikováno v:
Bulletin of the World Health Organization, Vol 89, Iss 11, Pp 821-830 (2011)
OBJECTIVE: To assess human papillomavirus (HPV) vaccination coverage after demonstration projects conducted in India, Peru, Uganda and Viet Nam by PATH and national governments and to explore the reasons for vaccine acceptance or refusal. METHODS: Va
Externí odkaz:
https://doaj.org/article/1ef5de0d473c4a8795b4894edb042dcd
Autor:
Sue J. Goldie, Carol Levin, N. Rocio Mosqueira-Lovón, Jesse Ortendahl, Jane Kim, Meredith O'Shea, Mireia Diaz Sanchez, Maria Ana Mendoza Araujo
Publikováno v:
Revista Panamericana de Salud Pública, Vol 32, Iss 6, Pp 426-434 (2012)
OBJECTIVE: To estimate the benefits, cost-effectiveness (i.e., value for money), and required financial costs (e.g., affordability) of adding human papillomavirus (HPV) vaccination to Peru's cervical cancer screening program. METHODS: Evidence (e.g.,
Autor:
N. Rocio Mosqueira, Nga Thi Le, Sanjay Gandhi, Aisha O. Jumaan, Mary E. Penny, D. Scott LaMontagne, Emmanuel Mugisha, Proma Paul, Nghi Quy Nguyen, Amynah Janmohamed, Yuxiao Tang, Edward Kumakech, Bella Patel Uttekar, Tran Hung Minh, Sandhya Barge
Publikováno v:
Bulletin of the World Health Organization. 89:821-830
OBJECTIVE: To assess human papillomavirus (HPV) vaccination coverage after demonstration projects conducted in India, Peru, Uganda and Viet Nam by PATH and national governments and to explore the reasons for vaccine acceptance or refusal. METHODS: Va
Autor:
Julia Fox-Rushby, Damian G. Walker, N. Rocio Mosqueira, Andrew Clark, Mary E. Penny, Colin Sanderson, Claudio F. Lanata
Publikováno v:
The Journal of Infectious Diseases. 200:S114-S124
BACKGROUND: There are plans to introduce the oral rotavirus vaccine Rotarix (GlaxoSmithKline), 1 of 2 recently developed vaccines against rotavirus, in Peru. METHODS: We modeled the cost-effectiveness of adding a rotavirus vaccine to the Peruvian imm
Autor:
Sue J, Goldie, Carol, Levin, N Rocio, Mosqueira-Lovón, Jesse, Ortendahl, Jane, Kim, Meredith, O'Shea, Mireia, Diaz Sanchez, Maria Ana, Mendoza Araujo
Publikováno v:
Revista panamericana de salud publica = Pan American journal of public health. 32(6)
To estimate the benefits, cost-effectiveness (i.e., value for money), and required financial costs (e.g., affordability) of adding human papillomavirus (HPV) vaccination to Peru's cervical cancer screening program.Evidence (e.g., coverage, delivery c
Autor:
Mireia Diaz Sanchez, Carol Levin, Jane J. Kim, Sue J. Goldie, Jesse D. Ortendahl, Meredith O'Shea, N. Rocio Mosqueira-Lovón, Maria Ana Mendoza Araujo
Publikováno v:
Scopus-Elsevier
OBJECTIVE: To estimate the benefits, cost-effectiveness (i.e., value for money), and required financial costs (e.g., affordability) of adding human papillomavirus (HPV) vaccination to Peru's cervical cancer screening program. METHODS: Evidence (e.g.,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::619defaff0f084e133a55d679bc08e07
http://www.scopus.com/inward/record.url?eid=2-s2.0-84874869518&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84874869518&partnerID=MN8TOARS
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.